The Tumor Vaccine Group at the University of Washington is a multidisciplinary group of investigators focused on the diagnosis, prevention and treatment of cancer with novel, immune-based approaches. Involving scientists, doctors, nurses, and patients, our translational research works to bring the most innovative treatments from the bench to the bedside and to harmonize scientific study with patient care.
In the News:
- Seattle Magazine (Feb 2017): Dr. Disis voted one of Seattle's Top Doctors in 2017!
- Rivkin Center (Nov 2016): Importance of Research
- NCI Cancer Prevention Program (Jul 2016): Polyvalent Vaccine Targeting Oncogenic Driver Pathways